Literature DB >> 7850929

Nitric oxide mediates the blood flow response to intravenous adenosine in the rabbit.

L D McKie1, B L Bass, B J Dunkin, J W Harmon.   

Abstract

The objective of this study was to determine if nitric oxide mediates the effects of exogenously administered adenosine on peripheral blood flow. An intravenous infusion of adenosine (1.0 mumol/kg/min) into male New Zealand white rabbits caused an increase in blood flow, measured using radiolabeled microspheres, throughout the gastrointestinal tract, as well as in the heart and kidneys. Prior administration of nitro-L-arginine methyl ester (L-NAME) 10 mg/kg i.v. completely blocked the hyperemic effect of adenosine on all organs studied. Administration of L-arginine (300 mg/kg bolus and 50 mg/kg/min infusion) together with L-NAME restored the hyperemic effect of adenosine. This phenomenon was specified to the L-arginine/nitric oxide pathway in that a similar pressor response induced by phenylephrine (1.5 micrograms/kg/min) did not block the effects of adenosine. We conclude that the peripheral vasodilator response to intravenously administered adenosine in the rabbit is mediated by nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7850929

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  3 in total

1.  Attenuation of ischemic liver injury by augmentation of endogenous adenosine.

Authors:  S Todo; Y Zhu; S Zhang; M B Jin; N Ishizaki; H Tanaka; V Subbotin; T E Starzl
Journal:  Transplantation       Date:  1997-01-27       Impact factor: 4.939

Review 2.  Factors in the pathophysiology of the liver ischemia-reperfusion injury.

Authors:  Eduardo E Montalvo-Jave; Tomas Escalante-Tattersfield; Jose A Ortega-Salgado; Enrique Piña; David A Geller
Journal:  J Surg Res       Date:  2007-07-27       Impact factor: 2.192

3.  NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis.

Authors:  D A Fryburg
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.